Amelanotic malignant melanoma in the oral region is extremely rare and has not previously been reported in the parotid gland. This present case report describes an amelanotic malignant melanoma in the parotid gland, with no other primary lesion detectable. The medical history, pathology and immunohistochemical analysis of the case are described and the relevant literature is reviewed in order to help in the recognition of this uncommon tumour. Amelanotic malignant melanoma is a melanoma subtype with little or no pigmentation and, because of this lack of pigmentation and its wide-ranging clinical appearance, it often defies clinical diagnosis. A high level of vigilance is, therefore, necessary in diagnosing such a tumour in the parotid gland. Where it is suspected, positive expression of S-100 protein and human melanoma black 45 (HMB45) using immunohistochemical analysis can be considered reliable methods of confirming diagnosis.
Introduction
Primary malignant melanomas of the parotid gland are extremely rare and recognition of their features is based mainly on sporadic case reports. 1 -5 Here, a case is presented that not only fulfils the criteria for a diagnosis of primary malignant melanoma of the parotid gland, but also has the clinical and pathological characteristic of amelanotic malignant melanoma (AMM). To our knowledge AMM, a melanoma subtype with little or no pigmentation, has not been previously reported in the parotid gland. The present report describes the medical history, pathology and immunohistochemical analysis of the case and reviews the relevant literature that might contribute to the recognition of this uncommon tumour.
Case report
In October 2006, a 37-year-old Tibetan male was admitted to the West China Stomatology Hospital of Sichuan University with a 2month history of a progressively enlarging mass in the left parotid region that had recently increased rapidly in size, accompanied by severe and constant pain. Physical examination revealed a hard mass, which was fixed to the underlying soft Parotid gland primary amelanotic malignant melanoma tissues in the left parotid region and measured about 6 × 4 × 4 cm with an undefined boundary. There was no functional impairment of the facial nerve. A tender and unfixed cervical lymph node measuring 1.0 × 0.8 × 0.6 cm could be palpated. The skin of the maxillofacial and cervical regions was normal in appearance and no lesions were found in the oral cavity.
The usual pre-operative workup was implemented. Computerized tomography of the head and neck region demonstrated a large mass in the left parotid gland with an obscure boundary. Chest radiography was normal. Laboratory studies, which included full blood cell count, electrolytes, urinalysis and liver function tests, all had results within normal limits.
Subsequently the patient underwent a total left parotidectomy with resection of contiguous soft tissues, including part of the masseter, whilst preserving the facial nerve. The tumour specimen measured 5.0 × 3.5 × 3.5 cm occupying almost the entire parotid gland. On dissection, the tumour appeared as a whitish, lobulated solid with some areas of necrosis. Intra-operative frozen-section examination was performed for diagnostic purposes and to indicate a safe surgical margin.
Several days after the operation, histopathological examination of a specimen fixed in buffered formalin along with immunohistochemical analysis confirmed the lesion to be an amelanotic malignant melanoma. Microscopically, there was no evidence of a lymph node structure in the main tumour. Melanocytic nests displayed nodules and lobes, some invaded the parotid gland tissue or completely replaced it ( Fig. 1 ) and some were separated by connective septa. The tumour cells varied from polygonal to spindle shaped and a few contained yellowish brown granules (Fig. 2 ). Immunohistochemical expression of S-100 protein and human melanoma black 45 Subsequently, careful physical examination, gastrointestinal endoscopy, abdominal ultrasound and epipharyngoscopy were performed to search for other melanomatous lesions. The outcome was negative. Further therapy plans including left radical neck dissection and immunotherapy were recommended but, unfortunately, the patient refused these. Two months later, an apparent metastasis was observed in the left neck and 5 months after operation the patient died of widespread metastases.
Discussion
Primary malignant melanoma of the parotid gland is extremely rare. The majority of malignant melanomas in the parotid gland appear to be associated with lymph node metastasis in and around the gland from a cutaneous primary in the head region. 6 Since melanocytes derive embryologically from the neural crest and do not usually form part of the salivary tissue, the definition of primary melanomas of the parotid remains controversial. 3, 7 While Greene and Bernier 3 reasoned that melanoblasts would become a part of the parotid gland with the downgrowth of oral epithelium during the development of the parotid, they also found that some cells in the normal human parotid gland tested positive for melanin when stained using the L-DOPA (3,4-dihydroxy-L-phenylalanine) method. Moreover, in 1997 Takeda 8 found melanocytes in the interlobular duct of the parotid gland during an autopsy performed on a Japanese male. These findings demonstrate that the occurrence of malignant melanoma in the parotid gland as a primary lesion is possible.
Based on past reports, several criteria for the diagnosis of primary melanoma have been established, as follows: (i) the predominant tumour mass should be intra-parotid; (ii) there should be no identifiable lymph node tissue present in the mass; (iii) there should be no evidence of malignant melanoma elsewhere after a diligent search of the eyes, skin, nose, pharynx, mouth, oesophagus, anogenital region and meninges; and (iv) there should be no evidence of previous excision of a malignant melanoma or progressing pigmented lesion. 2, 3 The present case fulfils these criteria and so the diagnosis of a primary tumour is reasonable. Furthermore, the present case also had the clinical and pathological hallmarks of AMM, which accounts for 1.8 -8.1% of all malignant melanomas. 9, 10 Oral AMM is, however, extremely rare. 11 To our knowledge, it has not previously been reported in the parotid gland, which may be due both to its low incidence and to misdiagnosis. AMM often defies clinical diagnosis because of its wide-ranging clinical appearance and lack of pigmentation. Histologically it resembles atypical fibroxanthoma, malignant fibrous histiocytoma, malignant schwannoma or spindle cell squamous cell carcinoma, which can result in misdiagnosis and improper treatment. In such cases, immunohistochemistry provides a valuable tool for ensuring a correct diagnosis. 11 In the present case, there was no history of malignant melanoma and no pigmentation lesion which, coupled with the rare incidence of AMM, made it more difficult to give a final diagnosis until the results of immunohistochemical analysis were obtained. The standard melanoma immunohistochemical antigens, S-100 protein and HMB-45 were used to confirm the diagnosis, whilst CK and EMA were used for differential diagnosis. Both S-100 protein and HMB-45 expression were positive in the specimen, which was in
